+

WO2008035360A3 - Nouvelles formes cristallines - Google Patents

Nouvelles formes cristallines Download PDF

Info

Publication number
WO2008035360A3
WO2008035360A3 PCT/IN2007/000236 IN2007000236W WO2008035360A3 WO 2008035360 A3 WO2008035360 A3 WO 2008035360A3 IN 2007000236 W IN2007000236 W IN 2007000236W WO 2008035360 A3 WO2008035360 A3 WO 2008035360A3
Authority
WO
WIPO (PCT)
Prior art keywords
candesartan
tritylated
cilexetil
novel crystalline
crystalline forms
Prior art date
Application number
PCT/IN2007/000236
Other languages
English (en)
Other versions
WO2008035360A2 (fr
Inventor
Pandurang Balwant Deshpande
Parven Kumar Luthra
Dhiraj Mohansinh Rathod
Lalitkumar Keshavlal Katariya
Himanshu Manojkumar Mehta
Original Assignee
Alembic Ltd
Pandurang Balwant Deshpande
Parven Kumar Luthra
Dhiraj Mohansinh Rathod
Lalitkumar Keshavlal Katariya
Himanshu Manojkumar Mehta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd, Pandurang Balwant Deshpande, Parven Kumar Luthra, Dhiraj Mohansinh Rathod, Lalitkumar Keshavlal Katariya, Himanshu Manojkumar Mehta filed Critical Alembic Ltd
Publication of WO2008035360A2 publication Critical patent/WO2008035360A2/fr
Publication of WO2008035360A3 publication Critical patent/WO2008035360A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouvelles formes cristallines de candésartan cilexétil conçues sous forme G et H et une nouvelle forme cristalline de candésartan, de candésartan tritylé et de candésartan cilexétil tritylé, ainsi qu'un procédé pour leur préparation.
PCT/IN2007/000236 2006-06-13 2007-06-12 Nouvelles formes cristallines WO2008035360A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN928MU2006 2006-06-13
IN928/MUM/2006 2006-06-13

Publications (2)

Publication Number Publication Date
WO2008035360A2 WO2008035360A2 (fr) 2008-03-27
WO2008035360A3 true WO2008035360A3 (fr) 2008-10-16

Family

ID=39190284

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000236 WO2008035360A2 (fr) 2006-06-13 2007-06-12 Nouvelles formes cristallines

Country Status (1)

Country Link
WO (1) WO2008035360A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7692023B2 (en) 2004-02-11 2010-04-06 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
HUP0900376A2 (en) 2009-06-19 2011-01-28 Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag Nanoparticulate candesartan cilexetil composition
WO2011092666A1 (fr) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited Procede ameliore de preparation de candesartan cilexetil, formes polymorphes de n-trityl candesartan et leurs utilisations
US20180155326A1 (en) * 2015-06-05 2018-06-07 Zhejiang Huahai Pharmaceutical Co., Ltd. Method for preparing trityl candesartan
CN109627234A (zh) * 2019-01-30 2019-04-16 浙江省食品药品检验研究院 一种坎地沙坦酯晶体及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0459136A1 (fr) * 1990-04-27 1991-12-04 Takeda Chemical Industries, Ltd. Dérivés de benzimidazole, leur préparation et utilisation
WO2004085426A1 (fr) * 2003-03-27 2004-10-07 Hetero Drugs Limited Nouvelles formes cristallines de candesartan cilexetil
WO2005077941A2 (fr) * 2004-02-11 2005-08-25 Teva Pharmaceutical Industries Ltd. Polymorphes de candesartan cilexetil
WO2005123721A2 (fr) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited Formes amorphes et polymorphes de candesartan cilexetil
EP1655298A1 (fr) * 2004-11-03 2006-05-10 LEK Pharmaceuticals d.d. Formes polymorphes du candesartan cilexetil

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0459136A1 (fr) * 1990-04-27 1991-12-04 Takeda Chemical Industries, Ltd. Dérivés de benzimidazole, leur préparation et utilisation
WO2004085426A1 (fr) * 2003-03-27 2004-10-07 Hetero Drugs Limited Nouvelles formes cristallines de candesartan cilexetil
WO2005077941A2 (fr) * 2004-02-11 2005-08-25 Teva Pharmaceutical Industries Ltd. Polymorphes de candesartan cilexetil
WO2005123721A2 (fr) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited Formes amorphes et polymorphes de candesartan cilexetil
EP1655298A1 (fr) * 2004-11-03 2006-05-10 LEK Pharmaceuticals d.d. Formes polymorphes du candesartan cilexetil

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BRITAIN ET AL: "Polymorphism in Pharmaceutical Solids passage", POLYMORPHISM IN PHARMACEUTICAL SOLIDS, 1999, pages 235 - 238, XP002278123 *
CAIRA M R: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1998, pages 163 - 208, XP001156954, ISSN: 0340-1022 *
FERNANDEZ, DANIEL ET AL: "Candesartan cilexetil, an antihypertensive agent containing an extended double ester chain", ACTA CRYSTALLOGRAPHICA, SECTION E: STRUCTURE REPORTS ONLINE, vol. E61, no. 2, 2005, pages O309 - O312, XP002474295 *
HIROKAZU MATSUNAGA ET AL: "Solid-state characterization of candesartan cilexetil (TCV-116): crystal structure and molecular mobility", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, JP, vol. 47, no. 2, February 1999 (1999-02-01), pages 182 - 186, XP002957606, ISSN: 0009-2363 *

Also Published As

Publication number Publication date
WO2008035360A2 (fr) 2008-03-27

Similar Documents

Publication Publication Date Title
WO2009025876A8 (fr) Formes cristallines de chlorhydrate d'erlotinib et formulations de celles-ci
WO2008149345A3 (fr) Composés triarylés et compositions les comprenant
DK3872058T3 (en) Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
WO2007127292A3 (fr) Formes cristallines de tigecycline et leurs procedes de preparation
HK1201822A1 (en) Process for the preparation of 5,6-dihydro-1h-pyridin-2-one compounds 56--1h--2-
WO2007093627A3 (fr) Composition biocide
WO2006074951A3 (fr) Composition d'olanzapine ou de donepezil a desintegration orale
WO2007139871A3 (fr) Méthodes et matières pour l'élaboration de simvastatine et de ses composés
ZA200904333B (en) Process for the preparation of 6,6-Dimethyl-3-azabicyclo-[3.1.0]-hexane compounds utilizing bisulfite intermediate
WO2008021342A3 (fr) Formes cristallines de la 9-hydroxy-rispéridone (palipéridone)
MX2009008660A (es) Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
WO2008140641A3 (fr) Palipéridone pure et ses procédés de préparation
WO2008088779A3 (fr) Formes solides de 5-azacytidine et procédés de préparation de ces dernières
WO2008083130A3 (fr) Compositions à base de carvédilol
WO2007132354A3 (fr) Procédé de préparation de voriconazole, nouvelle forme polymorphe d'un produit intermédiaire de ce composé et utilisations dudit composé
WO2007098273A3 (fr) Nouvelles formes cristallines d'armodafinil et leur preparation
WO2008075205A3 (fr) Procédé amélioré de préparation de la voriconazole
WO2008021346A3 (fr) Palipéridone pure et ses procédés d'obtention
WO2008035360A3 (fr) Nouvelles formes cristallines
WO2008137134A3 (fr) Bromhydrate d'élétriptan amorphe et son procédé de préparation, et autres formes de bromhydrate d'élétriptan
WO2009000533A8 (fr) Nouveaux herbicides
WO2010015656A3 (fr) Nouveaux alcoxypyrazoles
WO2010039885A3 (fr) Formes cristallines du dexlansoprazole
WO2009062659A3 (fr) Polymorphes d'erdostéine énantiopure
WO2008094617A3 (fr) Formes cristallines de déférasirox

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07859577

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07859577

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载